The Efficacy and Safety of Patiromer for Heart Failure Patients: A Systematic Review and Meta-Analysis.

Cardiovasc Drugs Ther · 2024 · PMC11680614 · PMID 37285082

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a possible trendno p-value reported

These discoveries revealed a possible trend: there was a difference between the long-term and short-term effects of patiromer in reducing the incidence of hyperkalemia in patients with HF.

also in 939 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.